GSK GSK plcStock Price & Overview
$41.11
Charts
Quant Ranking
GSK Analysis
GSK News
Latest Headlines
Ratings Summary
People Also Follow
Similar to GSK
ETFs Holding GSK
GSK Company Profile
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
GSK Revenue
GSK Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
GSK Dividend Growth History
GSK Ownership
GSK Peers
Risk
Technicals
GSK Transcripts
Investor Presentations
GSK SEC Filings
Press Releases
GSK Income Statement
GSK Balance Sheet
GSK Cash Flow Statement
GSK Long Term Solvency
Discover More
You may be interested in: